Tuberous Sclerosis
Tuberous sclerosis (TSC) is a single-gene disorder caused by heterozygous mutations in the TSC1 (9q34) or TSC2 (16p13.3) gene, and is frequently associated with mental retardation, autism and epilepsy. Even TSC individuals with a normal IQ (approximately 50%) are commonly affected with specific neuropsychological problems, including long-term and working memory deficits. We have demonstrated that mice with a heterozygous, inactivating mutation in the Tsc2 gene (Tsc2+/- mice) have deficits in learning and memory. Cognitive deficits in Tsc2+/- mice emerge in the absence of neuropathology and seizures, demonstrating that other disease mechanisms are involved. We show that in these mice hyperactive hippocampal mTOR signaling leads to abnormal hippocampal CA1 LTP and consequently to deficits in hippocampal-dependent learning. These deficits include impairments in two spatial learning tasks, and in contextual discrimination. Remarkably, we demonstrated that a brief treatment with the mTOR inhibitor rapamycin in adult mice can rescue not only the synaptic plasticity, but also the behavioral deficits in this animal model of TSC. Our results reveal a biological basis for some of the cognitive deficits associated with TSC and they show that treatment with mTOR antagonists ameliorates cognitive dysfunction in a mouse model of this disorder. We are currently involved in a collaboration to determine if the same treatment is efective in TSC patients.

|
Key Publication:
Ehninger, D., S. Han, C. Shilyansky, Y. Zhou, W. Li, D.J. Kwiatkowski, V. Ramesh, and A.J. Silva, Reversal of learning deficits in a Tsc2(+/-) mouse model of tuberous sclerosis. Nat Med, 2008.(Click Here)
|